I
N SEVERE illness of any cause, depression of thyroid hormone system may occur in otherwise euthyroid patients. In this condition, called the euthyroid sick syndrome, the normal feedback control of the thyroid homeostasis is changed. [1] [2] [3] Levels of thyrotropin do not increase, although levels of the active hormone triiodothyronine (T 3 ) become low. The conversion of the prohormone free thyroxine (T 4 ) into T 3 is hampered, and there is an accumulation of the inactive metabolite reverse T 3 (rT 3 ).
This syndrome has been found in severe chronic heart failure, 4 in acute myocardial infarction (AMI), 5, 6 and as a rapidly emerging phenomenon during open-heart surgery. 7 The more profound the changes in hormonepattern,thepoorertheprognosis. 8, 9 Triiodothyronine has profound effects on the cardiovascular system. It increases cardiac contractility and reduces systemic vascular resistance. 10, 11 These properties have made investigators explore potential benefits of thyroid hormone supplementation in conditions with poor heart function and low T 3 levels. The usefulness of T 3 as an inotropic agent has been studied in patients during open-heart surgery. Results have been promising, and few adverse reactions have been reported. [12] [13] [14] Experimental animal studies indicate that treatment with thyroid hormone may be beneficial in heart failure after AMI. [15] [16] [17] [18] The aims of the present investigation were to study changes in the thyroid hormone system in patients with AMI and to evaluate whether such changes are important for the outcome. 
ORIGINAL INVESTIGATION

PATIENTS AND METHODS
STUDY POPULATION
Blood samples were obtained from 54 consecutive patients presenting with chest pain and subsequently proven AMI on admission to the coronary care unit. Patients with known or suspected thyroid disease and patients taking medication that affected the thyroid hormone system (T 4 , glucocorticoids, amiodarone, heparin sodium) were excluded from further studies. Forty-seven patients remained for evaluation (mean±SD age, 69±13 years; range, 31-93 years; 16 women). Patient characteristics are given in Table 1 . As a control group, we used 123 healthy individuals (mean±SD age, 59±14 years; range, 31-86 years), none of whom were taking any medications. Regarding levels of rT 3 , another control group, consisting of 109 healthy, 70-year-old individuals taking no medications, was used ( Table 2) . Median delay from pain onset until the first sample was obtained was 7 hours 20 minutes. Only 4 patients arrived later than 24 hours and none later than 48 hours after onset of symptoms. For each patient, the time from pain onset, rather than the time from admission, was used in the analysis. Six patients died within the first year of AMI. After 2 years, 11 patients had died ( Table 3) .
BIOCHEMICAL ASSAYS
Blood samples were obtained on admittance to the coronary care unit and 4 times daily for 2 days, once daily for another 3 days, and during convalescence 6 and 12 weeks later. Samples were centrifuged for 10 minutes, and serum was aspirated and frozen at −20°C. Serum concentrations of total T 3 (T 3 ), free T 4 (FT 4 ), and thyrotropin were determined in a DELFIA system by dissociation-entranced lathamid pfluro-assay (Auto DELFIA; Wallac OY, Turku, Finland). The rT 3 was determined by Radioimmuno Assay (Biodata Diagnostic, Rome, Italy). Infarction size was estimated by serum levels of the isoenzyme creatine kinase-MB fraction (CK-MB). Peak levels of samples obtained every 6 hours until values had returned to normal were used. In addition, levels of troponin T obtained 18 ± 6 hours (mean ± SD) from the onset of symptoms were evaluated. The proinflammatory cytokine interleukin 6 (IL-6), which was determined in 28 patients only, was analyzed by enzyme immunoassay (IL-6 highsensitivity kit; R&D Systems, Abingdon, England). Standard hospital procedures were applied for quantification of C-reactive protein (CRP) and fasting morning samples of cortisol.
ECHOCARDIOGRAPHY
Examinations were performed the third day and after 6 weeks by the same observer. Systolic left ventricular function was evaluated by the mean displacement of the mitral annulus (atrioventricular [AV] plane) from the apical position. This method was chosen because of its relative insensitivity to regional wall motion disturbances. 19 In addition, it is a structure that is generally easily identified in patients with poor echocardiographic windows.
STATISTICAL ANALYSIS
Values concerning the entire study population are presented as mean ±SD. When groups are compared, SEM is used. A consequence of the differences in delay between pain onset and the first sample is that in the early intervals, before all of the patients had arrived, the number of patients presented does not include all 47 patients. (The number of patients presented in these intervals are as follows: 19 patients in the 0-to 6-hour period, 31 patients in the 6-to 12-hour period, 32 patients in the 12-to 18-hour period, and 38 patients in the 18-to 24-hour period). When more than 1 sample was acquired during the same period, mean values are presented. Nonparametric tests (MannWhitney U test, Wilcoxon signed rank test, and Spearman rank correlation) were used because of the limited number of patients. A 2-tailed P Ͻ.05 was regarded as significant. Informed consent was obtained, and the study was approved by the ethics committee of Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden.
RESULTS
THYROID HORMONES IN AMI
Total Triiodothyronine
The mean concentration of T 3 decreased successively after admission, reaching the lowest mean level 24 to 36 hours after pain onset. This level was 19% lower than during the first 6 hours (P = .02). The decrease from the first sample obtained to the lowest value for each patient was 23%±12% (P= .001). Compared with controls, levels of T 3 were depressed already within the first 6 hours (P=.001) ( Table 2 ). Longitudinal serum profiles for thyroid hormones are shown in Figure 1 .
Reverse T 3
The serum profile of rT 3 was reciprocal to T 3 ; values increased successively, reaching maximal levels 24 to 36 hours after pain onset, which were 22% higher than during the first 6 hours (P = .01) ( Figure 1 ). The mean increase from the first sample to the highest value was 37%±32% (PϽ.001). There was no difference in mean rT 3 levels during the first 6 hours between patients and controls. In the 24-to 36-hour interval, the mean level in the patient group was significantly higher: 29±1 ng/dL (0.45±0.02 nmol/L) vs 24±1 ng/dL (0.37±0.01 nmol/L) in controls (P =.005).
Free T 4
The mean concentration of the precursor hormone FT 4 was slightly higher during the first 18 hours than during the rest of the study period when the mean FT 4 level remained unchanged. Patient values fluctuated during the first 5 days without relation to the time for pain onset. Mean values for the whole group of patients did not differ significantly from the control group on any occasion.
Thyrotropin
Mean concentration of thyrotropin declined by 51% between the first 6-hour period and the 24-to 36-hour period (from 2.6±0.5 µIU/L to 1.3±0.1 µIU/L, PϽ.001). The mean thyrotropin level during the first 6 hours did not differ from the control group. In the 24-to 36-hour interval, patients had significantly lower values than controls (1.3±0.1 µIU/L vs 1.9±0.1 µIU/L, PϽ.001).
AGE AND SEX
In the patient group, negative correlation was found between age and T 3 levels during the first 5 days (r= -0.32, P=.005). Elderly patients tended to have higher FT 4 levels, although this was not significant (r =0.24, P=.11). In the control group, FT 4 but not T 3 correlated with age (r =0.29, P =.001). Levels of rT 3 and thyrotropin did not correlate with age among patients and controls. The thyroid hormones were not related to sex differences.
SEVERITY OF MYOCARDIAL DAMAGE
No relation was found between the occurrence of new Q waves on the electrocardiogram or whether patients had their first infarction and levels of any of the thyroid hormones during the first 5 days. Serum concentrations of cardiac enzymes did not correlate with mean levels of the thyroid hormones during the first 5 days. †Mean levels of thyroid hormones in patients with myocardial infarction during the first 6 hours compared with levels 24 to 36 hours from pain onset and mean values on admission compared with values of maximal change during the following 5 days. Individual levels of FT 4 fluctuated between 0.9 and 1.4 ng/dL without any relation to pain onset. ‡Levels of the thyroid hormones in 123 healthy controls (aged 59 ± 14 years) are shown for comparison. The normal value for rT 3 is from another population of 109 healthy 70-year-old men and women. When subgroup analysis was performed, correlation with cardiac enzymes was found in patients without history of angina pectoris preceding the AMI (n=26). In patients without angina, peak CK-MB levels correlated negatively with T 3 levels on the second day when changes were maximal (r=-0.52, P=.007) and positively with rT 3 levels (r=0.45, P=.02). Similar correlations were found between levels of troponin T and T 3 (r=-0.53, P=.009) and between troponin T and rT 3 
VENTRICULAR FUNCTION
Echocardiography during the hospital period showed correlations between the displacement of the AV plane and mean levels of the thyroid hormones during the whole hospital period. Thus, the displacement of the AV plane correlated with levels of T 3 (r = 0.36, P = .02), rT 3 (r = -0.44, P=.02), and FT 4 (r = -0.57, PϽ.001). No significant correlation with thyrotropin levels was found. Eleven patients with AV plane displacement less than 8 mm, corresponding to a left ventricular ejection fraction of approximately 35%, had a mean concentration of T 3 of 84±6 ng/dL (1.3 ± 0.1 nmol/L) compared with 104 ± 6 ng/dL (1.6±0.1 nmol) in other patients (P = .03).
On reexamination 6 weeks later, the displacement of the AV plane for the whole group of patients had increased 0.7±0.2 mm (P=.006). No correlation was found between changes in AV displacement and levels of T 3 , rT 3 , or thyrotropin. A modest negative correlation was found with FT 4 levels during the hospital period (r=-0.33, P=.045).
ANGINA PECTORIS
Patients with angina pectoris preceding AMI (n=21) had lower levels of T 3 during the first 24 hours than those without angina: 97±6 ng/dL (1.5±0.1 nmol/L) vs 117±6 ng/dL (1.8±0.1 nmol/L) (P=.008) ( Table 3 and Figure 2) . The lowest values were found in 4 patients with unstable angina (78±13 ng/dL [1.2±0.2 nmol/L]). The differences in T 3 levels between those with and those without angina were more pronounced the earlier the samples were obtained. Thus, during the first 6 hours, patients with angina had T 3 levels of 97±6 ng/dL (1.5±0.1 nmol/L) vs 130±13 ng/dL (2.0±0.2 nmol/L) in those without angina (P=.03) ( Table  3) . No differences between the groups were seen regarding rT 3 levels. Patients with a history of angina pectoris had higher FT 4 levels during the first 24 hours than others: 1.24±0.08 ng/dL (16±1 pmol/L) vs 1.2±0.1 ng/dL (14±1 pmol/L) (P=.01) ( Table 3 ). The highest levels of FT 4 were found in patients with unstable angina pectoris (1.5±0.2 ng/dL [20±3 pmol/L]). Levels of thyrotropin did not differ between the groups.
STRESS AND INFLAMMATION
The inflammatory markers IL-6 and CRP increased successively after AMI, with peaks occurring on the second and third days, respectively. On the second day, the mean IL-6 level correlated with peak levels of CK-MB (r=0.48, P = .009) (Figure 3) and troponin T levels (r = 0.59, P=.002). The mean CRP level on the third day correlated with peak CK-MB levels (r=0.34, P=.02) and troponin T levels (r=0.57, PϽ.001) (Figure 3 ). Patients with a history of angina pectoris had higher levels of CRP within the first 24 hours (33±10 mg/L vs 13±5 mg/L, P=.04) and tended to have higher levels of IL-6, although this finding was not significant (64±37 ng/L vs 23±7 ng/L, P=.21) ( Table 3 ). Figure 3 shows correlations on the second day between the mean levels of IL-6 vs T 3 and rT 3 , respectively. Peak levels of IL-6 correlated negatively with T 3 levels 24 to 36 hours after pain onset (r=-0.49, P=.005) and positively with rT 3 levels (r=0.41, PϽ.05) but not with levels of FT 4 or thyrotropin. There were tendencies to similar correlations between peak levels of CRP and levels of T 3 (r=−0.26, P=.07) and rT 3 (r=0.22, P=.15) in the 24-to 36-hour interval, but this was not significant. A significant correlation between CRP and T 3 levels was found when mean levels during all 5 days were used (r=-0.37, P=.01).
Fasting morning samples of cortisol were higher during the first days after AMI and declined successively. The maximum level was reached on the second day at 17±7 µg/dL (464±190 nmol/L). No correlation was found with levels of cardiac enzymes. Mean levels of cortisol during the first 5 days correlated with levels of rT 3 (r = 0.45, P=.002) and FT 4 (r=0.29, P=.048) but not with levels of T 3 or thyrotropin.
MORTALITY
Thyroid hormone levels differed between patients who died and the survivors. This was most obvious for T 3 (Figure 4) . Patients who died within the first year of AMI (n=6) had lower mean levels of T 3 and higher levels of rT 3 during the hospital period. Their FT 4 levels tended to be higher (P =.07), whereas their thyrotropin levels were lower. Values are given in Table 4 . The dif- ference in T 3 levels during the hospital period was significant between those who had died within 2 years following AMI (n = 11) and survivors.
COMMENT
The thyroid hormone system was transiently downregulated in otherwise euthyroid individuals during the acute phase of myocardial infarction. The changes in hormone levels were rapid during the first 24 hours after pain onset. Maximal changes were found in the 24-to 36-hour period. Compared with healthy controls, significant down-regulation was already evident on admission, indicating that the reaction may have started directly before or after coronary occlusion. The suppression of T 3 was more pronounced in patients who were old, had poor heart function, or had intense inflammatory reaction. Patients who died during follow-up had the most pronounced T 3 level depression. The finding of lower T 3 levels in the older patients was probably not due to age. In the control group, there was no correlation between age and T 3 levels. In the literature, opinions are conflicting on whether there is an age-dependent reduction in T 3 levels in healthy individuals. [20] [21] [22] In a study of 7248 healthy euthyroid individuals aged 3 months to 106 years, it was concluded that little change occurred after age 25 years. 23 The degree of hormone level depression did not seem to be related to the severity of AMI, as estimated by levels of cardiac enzymes, or by the occurrence of new Q waves on the electrocardiogram. This lack of relation has previously been reported but not explained. 5 The cause of the euthyroid sick syndrome is still poorly understood. The pathogenesis is probably multifactorial. The role of cytokines has recently been put into focus by studies demonstrating that administration of interferon alfa and IL-6 can induce changes in the thyroid hormone system, mimicking the euthyroid sick syndrome. 24, 25 In our study, we found negative correlations between levels of IL-6 and T 3 and between levels of CRP and T 3 , supporting this hypothesis. The increases in IL-6 and CRP levels were apparently related to the extent of myocardial damage and necrosis, since relatively strong correlations were found with cardiac enzymes.
Differences in levels of inflammatory mediators in patients with and without angina pectoris before the AMI may help explain why there was no correlation between cardiac enzymes and thyroid hormones. Patients with angina pectoris had higher levels of IL-6 and CRP and also more depressed thyroid hormone systems in early samples than others. Possibly, thyroid level depression was present before the infarction process started. Since patients with angina had infarctions that were much smaller than those in patients without angina, the relative rise in IL-6 and CRP levels after AMI was modest. When patients with and without angina were analyzed separately, correlation between cardiac enzymes and thyroid hormones was indeed found in patients without angina, but not in patients with angina, which seems to support this reasoning. To validate this hypothesis, it is necessary to study the thyroid hormones prospectively in patients with angina pectoris. Little has been done yet in this field of interest. The only publication, to our knowledge, is a report on 187 patients with coronary heart disease in whom signs of subclinical hypothyroidism was demonstrated in 60% of the patients. 26 The fact that patients with preceding angina had more depressed thyroid hormone systems on admission and subsequently developed smaller infarctions does not prove that there is a causal relationship. It is, however, plausible that down-regulation of the thyroid hormone system may be an advantage if it is present when AMI strikes because the oxygen demand of the myocardium may be reduced when the metabolic rate is diminished.
Whether the euthyroid sick syndrome is an advantage after AMI when damage has occurred and heart failure might be emerging may be questioned. Circumstances make it adequate to hypothesize that it may be deleterious. Thyroid hormones affect ventricular function through stimulation of sarcoplasmatic calcium adenosinetriphosphatase activity and expression. 27 This adenosinetriphosphatase is responsible for the removal of calcium from the cytosol during diastole, thereby allowing for uncoupling of actin-myosin cross-bridging. It is therefore of major importance for diastolic heart function. It also regulates the quantity of calcium in the sarcoplasmatic reticulum available for systolic contraction and is thus hereby also important for the systolic function of the heart. 28 When the thyroid hormone system is down-regulated in the short term in AMI, intracellular calcium handling is affected in a way that may contribute to myocardial stunning and reperfusion injury due to calcium overload. 29 Furthermore, down-regulation of the thyroid hormone system leads to increase in systemic vascular resistance and increased cardiac afterload. If the heart is unable to cope with this, cardiac output will be reduced.
If these seemingly disadvantageous effects of decreased production of biologically active T 3 were important, patients with more marked hormone derangement would have a worse prognosis regarding heart function and survival. In our study, we found no indications of such deleterious effects on the recovery of systolic function as measured by echocardiographic reexamination 6 weeks after AMI. However, we did find an association between the degree of thyroid hormone level depression and mortality.
Triiodothyronine has profound effects on the cardiovascular system, and it is likely that a short-term downregulation does affect outcome of AMI. With prospective studies on larger patient materials, evaluating stringent clinical end points and taking into consideration confounding factors such as age and infarction size, the cause and consequences of the euthyroid sick syndrome in AMI can be further clarified. Maybe this biochemical marker, in addition to others, can be helpful in predicting the outcome of our patients with coronary artery disease. 30 If this marker can be verified to be of significant importance for outcome in several prospective investigations, intervention studies on the thyroid hormone system may be initiated.
